Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001712467-19-000001
Filing Date
2019-07-23
Accepted
2019-07-23 14:42:56
Documents
1
Period of Report
2019-07-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3529
  Complete submission text file 0001712467-19-000001.txt   5001
Mailing Address 17 STATE STREET 7TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET 7TH FLOOR NEW YORK NY 10004 212-461-2315
TYME TECHNOLOGIES, INC. (Issuer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET 12TH FLOOR NEW YORK NY 10005
Business Address
Demurjian Michael (Reporting) CIK: 0001712467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38169 | Film No.: 19967638